Clinical trial
PET and Recovery Following Revascularization: Outcome and Cost-effectiveness of FDG PET in Left Ventricular Dysfunction (PARR 2)
NCT00385242 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PET and Recovery Following Revascularization: Outcome and Cost-effectiveness of FDG PET in Left Ventricular Dysfunction (PARR 2)
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2000
- Completion date
- June 30, 2011
- Enrollment
- 430 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.